-Reuters
Oppenheimer Maintains Outperform on AutoZone, Raises Price Target to $1850
Oppenheimer analyst Brian Nagel maintains AutoZone (NYSE:AZO) with a Outperform and raises the price target from $1670 to $1850.
Uncategorized
Morgan Stanley CEO Says All Losses Related To Archegos Are Reflected In First Quarter Earnings
-Reuters
Related Posts
Apple Car Project Loses 3 More Vital Engineers In Quick Succession
Apple Inc's (NASDAQ: AAPL) seven-year-old self-driving car project has lost three critical engineers in recent weeks,
Earnings Preview: Enfusion
Enfusion (NYSE:ENFN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement.
Analysts estimate that Enfusion will report an earnings per share (EPS) of $0.02.
Arbutus Biopharma Q3 EPS $(0.24), Inline, Sales $3.34M Beat $2.38M Estimate
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.24) per share which met the analyst consensus estimate. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year.